Aditxt
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2017-09-01
- Employees
- 47
- Market Cap
- -
- Website
- http://www.aditxt.com
- Introduction
Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Richmond, VA.
Immune Responses to COVID-19 Infection or Vaccination
Recruiting
- Conditions
- COVID-19
- Interventions
- Diagnostic Test: Laboratory assessment of antibody profiles
- First Posted Date
- 2022-05-18
- Last Posted Date
- 2022-05-18
- Lead Sponsor
- Aditxt, Inc.
- Target Recruit Count
- 600
- Registration Number
- NCT05379478
- Locations
- 🇺🇸
Aditxt, Richmond, Virginia, United States
© Copyright 2025. All Rights Reserved by MedPath